Suitability of four polymorphic DNA markers for indirect genetic diagnosis of haemophilia A in Japanese subject

Thrombosis Research
Akihiro SawadaEizo Kakishita

Abstract

Indirect genetic diagnosis using polymorphic DNA markers can detect carriers of haemophilia A (HA). These markers include CA repeat polymorphisms at intron 13 (CA-13) and CT-AG at intron 22 of the coagulation factor VIII (FVIII) gene, and also certain restriction fragment length polymorphisms (RFLPs) such as HindIII at intron 19 and BclI at intron 18. Recently, CA repeat polymorphism at intron 6 (CA-6) was also reported. We compared usefulness of the BclI RFLP, the HindIII RFLP, and CA-13 to that of CA-6. Heterozygosity of markers was examined in 282 X chromosomes obtained from 205 subjects including HA patients. Expected heterozygosity of the HindIII and BclI RFLPs was 30.0% and 27.9%, while observed heterozygosity was 28.0% and 26.5%. Expected heterozygosity of CA-13 was 45.6%, and observed heterozygosity was 40.0%. CA-6 showed two alleles with repeat numbers of 13 and 14, expected and observed heterozygosity were low (1.4% and 2.6%, respectively). When we used these markers in a HA lineage where the mother was a carrier according to coagulation factor assays, carrier diagnosis was possible using CA-13, the HindIII RFLP, and the BclI RFLP. This was not true for CA-6, for which the mother was homozygous. Although CA-13, and th...Continue Reading

References

Sep 1, 1990·British Journal of Haematology·J B GrahamS T Lord
Mar 21, 1998·British Journal of Haematology·H JarjanaziS H Cağlayan
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·S E Antonarakis
Feb 13, 2001·British Journal of Haematology·S R LinM C Shen

❮ Previous
Next ❯

Citations

Jan 22, 2005·Haemophilia : the Official Journal of the World Federation of Hemophilia·J-W KimH-M Ryu
Jan 18, 2006·Haemophilia : the Official Journal of the World Federation of Hemophilia·Y FangH-L Wang
Jun 9, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·J D MassaroA L Simões
Sep 11, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·G JayandharanA Srivastava
Apr 19, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Giuseppe CastaldoFrancesco Salvatore
Mar 29, 2014·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Tamouchin MoharramiMahmoud Shekari Khaniani
Jan 20, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Syed Tasleem RazaAshutosh Kumar
Sep 27, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Syed Tasleem Raza Avneesh
Dec 28, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Monica Singh, Puneetpal Singh
Jun 13, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·I R HusseinM El-Ekiabi
Jun 11, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Aveen M Raouf AbdulqaderSarwar Noori Mahmood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.